Spero Therapeutics, Inc. (SPRO)
USD 0.99
(-3.88%)
USD 0.99
(-3.88%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 96.73 Million | 48.57 Million | 18.25 Million | 9.33 Million | 4.74 Million | 3.96 Million |
| Cost of Revenue | 367 Thousand | 1.54 Million | 1.11 Million | 67 Million | 65.77 Million | 33.88 Million |
| Gross Profit | 96.36 Million | 47.03 Million | 17.13 Million | -57.67 Million | -61.03 Million | -29.91 Million |
| Operating Expenses | 75.25 Million | 79.14 Million | 106.22 Million | 88.44 Million | 67.95 Million | 42.8 Million |
| Selling, General and Administrative Expenses | 25.55 Million | 36.48 Million | 41.7 Million | 21.44 Million | 15.58 Million | 12.88 Million |
| Research and Development Expenses | 51.44 Million | 47.59 Million | 64.52 Million | 67 Million | 65.77 Million | 33.88 Million |
| Other Expenses | - | -4.93 Million | -395 Thousand | 833 Thousand | -13.4 Million | 1.14 Million |
| Cost and Expenses | 76.99 Million | 79.14 Million | 106.22 Million | 88.44 Million | 67.95 Million | 42.8 Million |
| Operating Income | 21.48 Million | -42.19 Million | -87.97 Million | -79.11 Million | -63.21 Million | -42.8 Million |
| Interest Expense | - | 2.6 Million | 1.94 Million | - | - | 303 Thousand |
| Income Tax Expense | 2.59 Million | 1.61 Million | 1.54 Million | -761 Thousand | -750 Thousand | 1.14 Million |
| Earnings before Tax | 25.4 Million | -46.41 Million | -89.75 Million | -78.28 Million | -60.92 Million | -41.66 Million |
| Net Income | 22.8 Million | -48.02 Million | -91.3 Million | -77.51 Million | -60.17 Million | -41.66 Million |
| Earnings Per Share Basic | 0.43 | -1.28 | -2.96 | -3.46 | -3.31 | -2.60 |
| Earnings Per Share Diluted | 0.43 | -1.28 | -2.96 | -3.46 | -3.31 | -2.60 |
| Weighted Average Shares Outstanding | 52.7 Million | 37.58 Million | 30.89 Million | 22.38 Million | 18.16 Million | 16 Million |
| Weighted Average Shares Outstanding (Diluted) | 52.98 Million | 37.58 Million | 30.89 Million | 22.38 Million | 18.16 Million | 16 Million |
| Gross Margin | 1.00 | 0.97 | 0.94 | -6.18 | -12.87 | -7.54 |
| EBIT Margin | 0.28 | -0.39 | -4.79 | -8.48 | -13.33 | -10.79 |
| Profit Margin | 0.24 | -0.99 | -5.00 | -8.31 | -12.69 | -10.50 |
| EBITDA | 27.15 Million | -42.26 Million | -87.17 Million | -76.93 Million | -62.46 Million | -42.39 Million |
| Earnings Before Tax Margin | 0.22 | -0.87 | -4.82 | -8.48 | -13.33 | -10.79 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 6.01 Million | 4.2 Million | 71.82 Million | 96.73 Million | 25.47 Million | 788 Thousand |
| Cost of Revenue | 2000.00 | -5.06 Million | 38 Thousand | 367 Thousand | 108 Thousand | 9.51 Million |
| Gross Profit | 6.01 Million | 9.26 Million | 71.78 Million | 96.36 Million | 25.36 Million | -8.72 Million |
| Operating Expenses | 29.25 Million | 23.24 Million | 22.95 Million | 76.62 Million | 27.4 Million | 13.67 Million |
| Selling, General and Administrative Expenses | 5.53 Million | 5.91 Million | 6.43 Million | - | 5.7 Million | 6.09 Million |
| Research and Development Expenses | 23.72 Million | 17.33 Million | 16.52 Million | - | 16.39 Million | 9.51 Million |
| Other Expenses | 1000.00 | -14 Thousand | 3000.00 | -14 Thousand | 5.3 Million | -6000.00 |
| Cost and Expenses | 29.25 Million | 23.24 Million | 22.99 Million | 76.99 Million | 27.4 Million | 13.67 Million |
| Operating Income | -23.24 Million | -19.04 Million | 48.83 Million | 19.74 Million | -1.93 Million | -12.89 Million |
| Interest Expense | - | - | 961 Thousand | - | - | - |
| Income Tax Expense | - | -91.75 Thousand | 387 Thousand | 2.59 Million | -2.21 Million | -6000.00 |
| Earnings before Tax | -17.86 Million | -12.66 Million | 51.57 Million | 25.4 Million | -994 Thousand | -11.91 Million |
| Net Income | -17.86 Million | -12.66 Million | 51.19 Million | 22.8 Million | -3.2 Million | -11.91 Million |
| Earnings Per Share Basic | -0.33 | -0.24 | 0.97 | - | -0.06 | -0.23 |
| Earnings Per Share Diluted | -0.33 | -0.24 | 0.96 | - | -0.06 | -0.23 |
| Weighted Average Shares Outstanding | 53.95 Million | 53.52 Million | 52.99 Million | 52.7 Million | 52.71 Million | 52.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 53.95 Million | 53.52 Million | 53.1 Million | 52.98 Million | 52.71 Million | 52.57 Million |
| Gross Margin | 1.00 | 2.20 | 1.00 | 1.00 | 1.00 | -11.07 |
| EBIT Margin | -3.86 | -4.53 | 0.68 | - | -0.08 | -14.98 |
| Profit Margin | -2.97 | -3.01 | 0.71 | 0.24 | -0.13 | -15.12 |
| EBITDA | -23.23 Million | -19.04 Million | 48.87 Million | - | -1.93 Million | -11.8 Million |
| Earnings Before Tax Margin | -3.86 | -4.53 | 0.68 | 0.20 | -0.08 | -16.36 |
601108
300068
SNC
IVREF
NBRY
ZONE